GSK tries new indication for lupus drug Benlysta WRAL Tech Wire GSK is studying the Benlysta/azathioprine combination in patients who have a particular vasculitic disease called ANCA (Anti-neutrophil Cytoplasmic Antibodies) positive vasculitis. The high hopes for Benlysta centered around its status as the first new ... GlaxoSmithKline aims to pump up Benlysta with new vasculitis use GlaxoSmithKline announces start of phase III study of Benlysta in patients ... GLAXOSMITHKLINE PLC : GlaxoSmithKline Starts Study of Benlysta in Patients ... |
